Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1902 1
1919 1
1946 1
1947 1
1948 1
1949 1
1961 1
1965 1
1966 1
1976 2
1977 1
1983 3
1984 3
1987 3
1988 2
1989 3
1990 3
1991 2
1992 8
1993 5
1994 4
1995 6
1996 1
1997 6
1998 5
1999 10
2000 3
2001 4
2002 7
2003 5
2004 10
2005 7
2006 6
2007 11
2008 9
2009 3
2010 6
2011 9
2012 9
2013 13
2014 15
2015 21
2016 24
2017 31
2018 30
2019 18
2020 36
2021 32
2022 38
2023 24
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

415 results

Results by year

Filters applied: . Clear all
Page 1
Endometriosis biomarkers of the disease: an update.
Encalada Soto D, Rassier S, Green IC, Burnett T, Khan Z, Cope A. Encalada Soto D, et al. Among authors: cope a. Curr Opin Obstet Gynecol. 2022 Aug 1;34(4):210-219. doi: 10.1097/GCO.0000000000000798. Curr Opin Obstet Gynecol. 2022. PMID: 35895963 Review.
JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications.
Russell MD, Stovin C, Alveyn E, Adeyemi O, Chan CKD, Patel V, Adas MA, Atzeni F, Ng KKH, Rutherford AI, Norton S, Cope AP, Galloway JB. Russell MD, et al. Among authors: cope ap. Ann Rheum Dis. 2023 Aug;82(8):1059-1067. doi: 10.1136/ard-2023-224049. Epub 2023 May 29. Ann Rheum Dis. 2023. PMID: 37247942 Free PMC article.
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.
Kostine M, Finckh A, Bingham CO, Visser K, Leipe J, Schulze-Koops H, Choy EH, Benesova K, Radstake TRDJ, Cope AP, Lambotte O, Gottenberg JE, Allenbach Y, Visser M, Rusthoven C, Thomasen L, Jamal S, Marabelle A, Larkin J, Haanen JBAG, Calabrese LH, Mariette X, Schaeverbeke T. Kostine M, et al. Among authors: cope ap. Ann Rheum Dis. 2021 Jan;80(1):36-48. doi: 10.1136/annrheumdis-2020-217139. Epub 2020 Apr 23. Ann Rheum Dis. 2021. PMID: 32327425 Free PMC article.
Ethical dilemmas and reflexivity in qualitative research.
Reid AM, Brown JM, Smith JM, Cope AC, Jamieson S. Reid AM, et al. Among authors: cope ac. Perspect Med Educ. 2018 Apr;7(2):69-75. doi: 10.1007/s40037-018-0412-2. Perspect Med Educ. 2018. PMID: 29536374 Free PMC article.
Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation.
Liszewski MK, Kolev M, Le Friec G, Leung M, Bertram PG, Fara AF, Subias M, Pickering MC, Drouet C, Meri S, Arstila TP, Pekkarinen PT, Ma M, Cope A, Reinheckel T, Rodriguez de Cordoba S, Afzali B, Atkinson JP, Kemper C. Liszewski MK, et al. Among authors: cope a. Immunity. 2013 Dec 12;39(6):1143-57. doi: 10.1016/j.immuni.2013.10.018. Epub 2013 Dec 5. Immunity. 2013. PMID: 24315997 Free PMC article.
Rheumatoid arthritis prevention in arthralgia: fantasy or reality?
van Steenbergen HW, Cope AP, van der Helm-van Mil AHM. van Steenbergen HW, et al. Among authors: cope ap. Nat Rev Rheumatol. 2023 Dec;19(12):767-777. doi: 10.1038/s41584-023-01035-y. Epub 2023 Oct 9. Nat Rev Rheumatol. 2023. PMID: 37814057 Review.
Emerging therapies for pre-RA.
Cope AP. Cope AP. Best Pract Res Clin Rheumatol. 2017 Feb;31(1):99-111. doi: 10.1016/j.berh.2017.08.005. Epub 2017 Sep 11. Best Pract Res Clin Rheumatol. 2017. PMID: 29221603 Review.
Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming.
Cooles FAH, Tarn J, Lendrem DW, Naamane N, Lin CM, Millar B, Maney NJ, Anderson AE, Thalayasingam N, Diboll J, Bondet V, Duffy D, Barnes MR, Smith GR, Ng S, Watson D, Henkin R, Cope AP, Reynard LN, Pratt AG; RA-MAP Consortium; Isaacs JD. Cooles FAH, et al. Among authors: cope ap. Ann Rheum Dis. 2022 Jun 9;81(9):1214-23. doi: 10.1136/annrheumdis-2022-222370. Online ahead of print. Ann Rheum Dis. 2022. PMID: 35680389 Free PMC article.
Mechanisms of checkpoint inhibition-induced adverse events.
Urwyler P, Earnshaw I, Bermudez M, Perucha E, Wu W, Ryan S, Mcdonald L, Karagiannis SN, Taams LS, Powell N, Cope A, Papa S. Urwyler P, et al. Among authors: cope a. Clin Exp Immunol. 2020 May;200(2):141-154. doi: 10.1111/cei.13421. Epub 2020 Feb 21. Clin Exp Immunol. 2020. PMID: 31989585 Free PMC article. Review.
415 results